Page 29 - Central Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axiom Presents “Unified Platforms: Key Modules and Data Considerations for Study ... Axiom Real-Time Metrics IncApril 9, 2021 GMT TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at the annual Outsourcing in Clinical Trials Israel on April 12th, 2021. As the key clinical outsourcing platform for biotech, pharmaceutical a...

Colon cancer screening could save your life More than 150,000 Americans develop colorectal cancer each year. The good news?Colorectal cancer is preventable, detectable, and if found early, treatable. By: Sponsored Content and last updated 2021-03-04 11:10:55-05 More than 150,000 Americans develop colorectal cancer each year, making it the second most common cancer related cause of death in the United States. The good news? Colorectal cancer is preventable, detectable, and if found early, treatable. According to the American Cancer Society, 9 out of 10 times early treatment sa...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test Lucira Health Files for $115M IPO Spectrum Solutions Gets CE Mark ...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigen...

Will Personalized Companion Diagnostics become the norm for diagnostics? Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find out the latest outlook for this important market. Learn all about how diagnostic players are jockeying for position with their pha...